Deadly RNA Viruses (eBook, ePUB)

This book provides information about the deadly viruses causing the pandemics in the world and provides clarity about the epidemiology of the diseases.Deadly RNA Viruses: Diagnosis, Detection, and Mitigation of Epidemics and Pandemics presents information about the available drugs, new drug discovery/development, and vaccines against deadly viruses. The international team of contributing authors discusses diagnosis through artificial intelligence and machine learning for early detection, as well as prevention, and treatment of various viruses. The authors also review etiology, epidemiology, an...

Weiterlesen / Aufklappen

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Geräte: eReader
mit Kopierschutz
eBook Hilfe
Größe: 21.18MB

Barrierefreiheit

Text-to-Speech
E-Mail des Verlags für Barrierefreiheitsfragen: ebookqueries@tandf.co.uk
Alle Inhalte über Screenreader oder taktile Geräte zugänglich
Alle Texte können hinsichtlich Größe, Schriftart und Farbe angepasst werden
ARIA-Rollen für verbesserte strukturelle Navigation
Navigation über vor-/zurück-Elemente ohne Inhaltsverzeichnis
Inhalte verständlich ohne Farbwahrnehmung
Seitennummerierung folgt dem gedruckten Werk
Ausführliche Alternativtexte für nicht-textuelle Inhalte vorhanden
Kurze Alternativtexte für nicht-textuelle Inhalte vorhanden
Text und Medien in logischer Lesereihenfolge angeordnet
Navigierbarer Index mit direktem Zugriff auf Indexbegriffe
Navigierbares Inhaltsverzeichnis für direkten Zugriff auf Text und Medien
Keine Einschränkung der Vorlesefunktionen, außer bei spezifischen Ausnahmen
Entspricht EPUB Accessibility Specification 1.1

Prof. V. Samuel Raj is a Professor of Microbiology & Biotechnology, Director of the Centre for Drug Design Discovery, and Development (C4D), and Dean of Academic Affairs at SRM University, Delhi-NCR, Haryana, India. He established the Centre for Drug Design Discovery and Development (C4D) at SRM University in 2014. He has more than 10 years of research and development (R&D) experience from two major pharmaceutical giants, Ranbaxy and Daiichi Sankyo, and more than three decades of international and national research experience in infectious diseases including virology. He has made significant contributions in the field of infectious diseases including HIV, dengue, and SARS-CoV-2 (COVID-19). He specializes in R&D in the field of drug discovery with applied clinical outcomes. He leads a team of academicians and researchers who work on containing the pandemic of antimicrobial resistance worldwide. Dr. V.M. Katoch is a NASI-ICMR Chair in Public Health Research at Rajasthan University of Health Sciences, Jaipur, India, and President of JIPMER, Puducherry, India. He is the former Secretary of the Department of Health Research, Ministry of Health & Family Welfare, and former Director-General of the Indian Council of Medical Research, Government of India, as well as former Director of JALMA, Agra, India. Dr. Katoch is the recipient of various awards and a Fellow of all the National Science Academies in India. As the Founder Secretary of Health Research, Government of India, he played an important role in developing and implementing the Virology Research Laboratories in all the states and medical colleges. Prof. N.K. Ganguly is the former Director-General of the Indian Council of Medical Research, Government of India; Visiting Professor of Eminence at the Policy Center for Biomedical Research, Translational Health Science & Technology Institute, Faridabad, India; Honorary Senior Research Professor (Clinical Research) at the Institute of Liver & Biliary Sciences, New Delhi, India; Professor at the Ganga Ram Institute for Postgraduate Medical Education & Research, Sir Ganga Ram Hospital, New Delhi; and Distinguished Professor at SRM University, Delhi-NCR, India. His major areas of research have been infectious diseases including viral diseases, cardiovascular diseases and diarrheal diseases. He has been appointed as a member of the Global Work Group of the Advisory Committee to the Director of the Centers for Disease Control, Atlanta, USA.

Produktdetails